131 related articles for article (PubMed ID: 32139156)
1. The diagnostic and prognostic roles of serum irisin in bladder cancer.
Esawy MM; Abdel-Samd KM
Curr Probl Cancer; 2020 Aug; 44(4):100529. PubMed ID: 32139156
[TBL] [Abstract][Full Text] [Related]
2. Serum irisin is a novel biomarker for bladder cancer detection.
Taken K; Aslan R; Eryilmaz R; Alp HH; Huyut Z; Dönmez Mİ
Int Urol Nephrol; 2022 Jan; 54(1):55-61. PubMed ID: 34807348
[TBL] [Abstract][Full Text] [Related]
3. Serum CA 19-9 as a good prognostic biomarker in patients with bladder cancer.
Wang QH; Ji ZG; Chen ZG; Li HZ; Fan H; Fan XR; Shi BB; Fang Y
Int J Surg; 2015 Mar; 15():113-6. PubMed ID: 25647541
[TBL] [Abstract][Full Text] [Related]
4. Serum Irisin: A Potential Diagnostic Marker for Insulin Resistance in Acne Vulgaris.
Tang L; Yu B; Liao Y; Long S; Yan H; He Q; Li C
Indian J Dermatol; 2022; 67(4):477. PubMed ID: 36578741
[TBL] [Abstract][Full Text] [Related]
5. Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics.
Provatopoulou X; Georgiou GP; Kalogera E; Kalles V; Matiatou MA; Papapanagiotou I; Sagkriotis A; Zografos GC; Gounaris A
BMC Cancer; 2015 Nov; 15():898. PubMed ID: 26560078
[TBL] [Abstract][Full Text] [Related]
6. Circulating Irisin Levels and Redox Status Markers in Patients with Gastric Cancer: A Case-Control Study.
Shahidi S; Hejazi J; Moghimi M; Borji S; Zabihian S; Fathi M
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2847-2851. PubMed ID: 33112539
[TBL] [Abstract][Full Text] [Related]
7. The Diagnostic Value of FNDC5/Irisin in Renal Cell Cancer.
Altay DU; Keha EE; Karagüzel E; Menteşe A; Yaman SO; Alver A
Int Braz J Urol; 2018; 44(4):734-739. PubMed ID: 29522296
[TBL] [Abstract][Full Text] [Related]
8. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
9. The association of circulating irisin with metabolic risk factors in Chinese adults: a cross-sectional community-based study.
Tang L; Tong Y; Zhang F; Chen G; Zhang YC; Jobin J; Tong N
BMC Endocr Disord; 2019 Dec; 19(1):147. PubMed ID: 31881940
[TBL] [Abstract][Full Text] [Related]
10. Serum irisin is upregulated in patients affected by amyotrophic lateral sclerosis and correlates with functional and metabolic status.
Lunetta C; Lizio A; Tremolizzo L; Ruscica M; Macchi C; Riva N; Weydt P; Corradi E; Magni P; Sansone V
J Neurol; 2018 Dec; 265(12):3001-3008. PubMed ID: 30350169
[TBL] [Abstract][Full Text] [Related]
11. Characterization of serum irisin in patients with severe acute pancreatitis.
Chen S; Wang L; Gao X; Chen M; Zeng Z; Zhao L
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):985-991. PubMed ID: 31180990
[TBL] [Abstract][Full Text] [Related]
12. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
13. Serum-based protein biomarkers of bladder cancer: A pre- and post-operative evaluation.
Bansal N; Gupta AK; Gupta A; Sankhwar SN; Mahdi AA
J Pharm Biomed Anal; 2016 May; 124():22-25. PubMed ID: 26922578
[TBL] [Abstract][Full Text] [Related]
14. Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study.
Saadeldin MK; Elshaer SS; Emara IA; Maged M; Abdel-Aziz AK
PLoS One; 2018; 13(11):e0206761. PubMed ID: 30403705
[TBL] [Abstract][Full Text] [Related]
15. Serum Irisin Predicts Mortality Risk in Acute Heart Failure Patients.
Shen S; Gao R; Bei Y; Li J; Zhang H; Zhou Y; Yao W; Xu D; Zhou F; Jin M; Wei S; Wang K; Xu X; Li Y; Xiao J; Li X
Cell Physiol Biochem; 2017; 42(2):615-622. PubMed ID: 28595171
[TBL] [Abstract][Full Text] [Related]
16. Association of serum concentrations of irisin and the adipokines adiponectin and leptin with epicardial fat in cardiovascular surgery patients.
Kaneda H; Nakajima T; Haruyama A; Shibasaki I; Hasegawa T; Sawaguchi T; Kuwata T; Obi S; Arikawa T; Sakuma M; Amano H; Toyoda S; Fukuda H; Inoue T
PLoS One; 2018; 13(8):e0201499. PubMed ID: 30071056
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs, miR-92a, miR-100 and miR-143, as non-invasive biomarkers for bladder cancer diagnosis.
Motawi TK; Rizk SM; Ibrahim TM; Ibrahim IA
Cell Biochem Funct; 2016 Apr; 34(3):142-8. PubMed ID: 26916216
[TBL] [Abstract][Full Text] [Related]
18. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of irisin is elevated in hypothyroidism, a case-control study.
Ateş İ; Altay M; Topçuoğlu C; Yılmaz FM
Arch Endocrinol Metab; 2016 Apr; 60(2):95-100. PubMed ID: 26201007
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer.
Zhang K; Zhou B; Zhang P; Zhang Z; Chen P; Pu Y; Song Y; Zhang L
Croat Med J; 2014 Oct; 55(5):507-13. PubMed ID: 25358883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
